These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 27533457)
1. Impacts of the mTOR gene polymorphisms rs2536 and rs2295080 on breast cancer risk in the Chinese population. Zhao Y; Diao Y; Wang X; Lin S; Wang M; Kang H; Yang P; Dai C; Liu X; Liu K; Li S; Zhu Y; Dai Z Oncotarget; 2016 Sep; 7(36):58174-58180. PubMed ID: 27533457 [TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of the effect of rs2295080 and rs2536 polymorphisms within the mTOR gene on cancer risk. Qi GH; Wang CH; Zhang HG; Yu JG; Ding F; Song ZC; Xia QH Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32597485 [TBL] [Abstract][Full Text] [Related]
3. [Association of mammalian target of rapamycin gene polymorphisms with the risk of pediatric epilepsy]. Yue X; Zhao PW; Liu ZS; Wu GF; Tu F; Hu JS; He XL Zhongguo Dang Dai Er Ke Za Zhi; 2015 Jun; 17(6):560-4. PubMed ID: 26108313 [TBL] [Abstract][Full Text] [Related]
4. Association of mTOR polymorphisms with cancer risk and clinical outcomes: a meta-analysis. Shao J; Li Y; Zhao P; Yue X; Jiang J; Liang X; He X PLoS One; 2014; 9(5):e97085. PubMed ID: 24816861 [TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in the mTOR gene and risk of sporadic prostate cancer in an Eastern Chinese population. Li Q; Gu C; Zhu Y; Wang M; Yang Y; Wang J; Jin L; Zhu ML; Shi TY; He J; Zhou X; Ye DW; Wei Q PLoS One; 2013; 8(8):e71968. PubMed ID: 23940798 [TBL] [Abstract][Full Text] [Related]
6. Association of genetic variations in mTOR with risk of childhood acute lymphoblastic leukemia in a Chinese population. Huang L; Huang J; Wu P; Li Q; Rong L; Xue Y; Lu Q; Li J; Tong N; Wang M; Zhang Z; Fang Y Leuk Lymphoma; 2012 May; 53(5):947-51. PubMed ID: 21973240 [TBL] [Abstract][Full Text] [Related]
7. Associations of Genetic Polymorphisms of mTOR rs2295080 T/G and rs1883965 G/A with Susceptibility of Urinary System Cancers. Min Z; Mi Y; Lv Z; Sun Y; Tang B; Wu H; Zhang Z; Pan H; Zhang Y; Lu C; Zuo L; Zhang L Dis Markers; 2022; 2022():1720851. PubMed ID: 35082928 [TBL] [Abstract][Full Text] [Related]
8. A polymorphism (rs2295080) in mTOR promoter region and its association with gastric cancer in a Chinese population. Xu M; Tao G; Kang M; Gao Y; Zhu H; Gong W; Wang M; Wu D; Zhang Z; Zhao Q PLoS One; 2013; 8(3):e60080. PubMed ID: 23555892 [TBL] [Abstract][Full Text] [Related]
9. Functional promoter rs2295080 T>G variant in MTOR gene is associated with risk of colorectal cancer in a Chinese population. Xu M; Gao Y; Yu T; Wang J; Cheng L; Cheng L; Cheng D; Zhu B Biomed Pharmacother; 2015 Mar; 70():28-32. PubMed ID: 25776475 [TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms of mTOR and cancer risk: a systematic review and updated meta-analysis. Zining J; Lu X; Caiyun H; Yuan Y Oncotarget; 2016 Aug; 7(35):57464-57480. PubMed ID: 27462867 [TBL] [Abstract][Full Text] [Related]
11. Effects of the mTOR and AKT genes polymorphisms on systemic lupus erythematosus risk. Saravani M; Shahraki-Ghadimi H; Maruei-Milan R; Mehrabani M; Mirzamohammadi S; Nematollahi MH Mol Biol Rep; 2020 May; 47(5):3551-3556. PubMed ID: 32319007 [TBL] [Abstract][Full Text] [Related]
12. Association of genetic variants in lncRNA GAS5/miR-21/mTOR axis with risk and prognosis of coronary artery disease among a Chinese population. Li H; Liu Y; Huang J; Liu Y; Zhu Y J Clin Lab Anal; 2020 Oct; 34(10):e23430. PubMed ID: 32557866 [TBL] [Abstract][Full Text] [Related]
13. Functional variant of MTOR rs2536 and survival of Chinese gastric cancer patients. Cheng L; Qiu L; Zhang R; Qian D; Wang M; Sun M; Zhu X; Wang Y; Guo W; Wei Q Int J Cancer; 2019 Jan; 144(2):251-262. PubMed ID: 29978580 [TBL] [Abstract][Full Text] [Related]
14. The possible effects of the MTOR polymorphisms on preeclampsia susceptibility, severity, and onset: a case-control study and in silico analysis. Rezaei M; Ghasemi M; Saravani M; Ghahghayi F; Shahraki-Ghadim H; Salimi S Mol Biol Rep; 2024 Feb; 51(1):335. PubMed ID: 38393518 [TBL] [Abstract][Full Text] [Related]
15. Effects of the MTOR and AKT1 genes polymorphisms on papillary thyroid cancer development. Maruei-Milan R; Saravani M; Heidari Z; Asadi-Tarani M; Salimi S IUBMB Life; 2020 Dec; 72(12):2601-2610. PubMed ID: 33107190 [TBL] [Abstract][Full Text] [Related]
16. Genetic association of deleted in colorectal carcinoma variants with breast cancer risk: A case-control study. Liu X; Wang X; Fu SW; Wang M; Kang H; Guan H; Zhang S; Ma X; Lin S; Liu K; Feng Y; Dai C; Dai Z Oncotarget; 2016 May; 7(22):32765-73. PubMed ID: 27127179 [TBL] [Abstract][Full Text] [Related]
17. Associations of PI3KR1 and mTOR polymorphisms with esophageal squamous cell carcinoma risk and gene-environment interactions in Eastern Chinese populations. Zhu J; Wang M; Zhu M; He J; Wang JC; Jin L; Wang XF; Xiang JQ; Wei Q Sci Rep; 2015 Feb; 5():8250. PubMed ID: 25654238 [TBL] [Abstract][Full Text] [Related]
18. Associations of genetic polymorphisms in pTEN/AKT/mTOR signaling pathway genes with cancer risk: A meta-analysis in Asian population. Zhang Z; Chen Q; Zhang J; Wang Y; Hu X; Yin S; He M; Guan S; Qin W; Xiao Q; Zhao H; Yao W; Wu H; Wei M Sci Rep; 2017 Dec; 7(1):17844. PubMed ID: 29259266 [TBL] [Abstract][Full Text] [Related]
19. Genetic variations in a PTEN/AKT/mTOR axis and prostate cancer risk in a Chinese population. Chen J; Shao P; Cao Q; Li P; Li J; Cai H; Zhu J; Wang M; Zhang Z; Qin C; Yin C PLoS One; 2012; 7(7):e40817. PubMed ID: 22815832 [TBL] [Abstract][Full Text] [Related]
20. Shafique R; Mahjabeen I; Bibi K; Kalsoom F; Rizwan M; Ashraf NS; Mehmood A; Ul Haq MF; Abbasi SF; Saeed N; Kayani MA Future Oncol; 2023 Sep; 19(28):1929-1943. PubMed ID: 37781867 [No Abstract] [Full Text] [Related] [Next] [New Search]